Prevalence and distribution of (micro)albuminuria in toddlers

Valentina Gracchi1, Sophie M van den Belt2, Leanne K Küpers3

  • 1Department of Pediatric Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Insights

Microalbuminuria, a marker for kidney and heart risks, appears to be congenital, present from birth. Its prevalence in toddlers mirrors that in adults, suggesting early origins and potential lifelong cardiovascular risk.

Area of Science:

  • Nephrology
  • Cardiology
  • Pediatrics
  • Public Health

Background:

  • Microalbuminuria affects approximately 7% of adults and is a significant indicator of renal and cardiovascular disease risks.
  • The origin of microalbuminuria, whether acquired during life or congenital, remains undetermined.
  • This study investigates the prevalence and potential congenital nature of microalbuminuria in young children.

Purpose of the Study:

  • To determine the prevalence of microalbuminuria in toddlers.
  • To compare albuminuria distribution in toddlers with that of the general adult population.
  • To explore associations between microalbuminuria and various antenatal, postnatal, and maternal factors.

Main Methods:

  • Urinary albumin concentration (UAC) and urinary albumin:creatinine ratio (UACR) were measured in 1352 children (20-40 months) from the GECKO cohort.
  • Albuminuria distribution was compared with data from 40,854 adults in the PREVEND study.
  • Linear regression analysis was used to identify associations between albuminuria and antenatal, postnatal, and maternal factors.

Main Results:

  • The median UAC and the prevalence of UAC ≥ 20 mg/L were comparable between toddlers (GECKO) and adults (PREVEND).
  • The prevalence of UACR ≥ 30 mg/g was 23.4% in toddlers.
  • Lower UAC and UACR were observed in boys; UACR was associated with age and gestational diabetes.

Conclusions:

  • The similar distribution of urinary albumin concentration and prevalence of elevated albuminuria in toddlers and adults suggests microalbuminuria may be a congenital condition.
  • Congenital microalbuminuria could predispose individuals to increased cardiovascular risk later in life.
  • Further research is needed to understand the long-term implications of early-life microalbuminuria.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
461
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
372
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
733
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
23
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.2K